A Laboratory and Clinical Comparison of National Local Formulation and Universal Formulation of Topical Prednisolone Acetate 1% in Reducing Inflammation After Phacoemulsification
published by Damascus University
in 2017
in Medicine
and research's language is
العربية
Download
Abstract in English
Purpose: To evaluate and compare the pharmacological characteristics and clinical efficacy of two topical steroid prednisolone preparations (Redmond®, prednisolone acetate 1%; and Pred Forte®, prednisolone acetate 1%) in reducing postoperative inflammation in patients having phacoemulsification surgery with IOL implantation, which will support our trust in national products considering it's availability and lower costs compared with universal products.
Methods:
I- Laboratory Study: Direct microscopic examination of the ophthalmic suspension for both formulations.
II- Clinical Study: This study was interventional, prospective, randomized controlled study included 60 eyes of patients undergoing emulsification surgery with IOL implantation. Patients were assigned to one of two treatment groups, The first group (30 eyes) received Redmond® while the second group (30 eyes) received Pred Forte® in addition to standard therapy. Study drug was administered postoperatively every 2 hours while awake for 7 days, then four times daily for 7 days, then twice daily for 7 days, then once daily for 7 days. Clinical efficacy was compared for differences in visual acuity, anterior chamber cells (scale 0-4), fundus and macula, drug's ocular adverse effects: foreign body sensation and irritation (scale 1-3), and intraocular pressure (IOP). Results were compared on day 1, day 3, 1 week, 2 weeks, and 1 month postoperatively.
Results:
I- Average particle size in ophthalmic suspension for both formulations was (< 1 μm). (Redmond® = 0.95 μm, Pred Forte® = 0.77 μm).
II- No statistical differences in clinical efficacy or safety were seen between the two formulations tested at any time point evaluated with respect to visual acuity, anterior chamber cells, fundus and macula, foreign body sensation and irritation, and intraocular pressure (IOP).
Conclusions: In this study of routine cataract patients, both prednisolone acetate 1% formulations are comparably effective and safe when administered for the reduction of inflammation after phacoemulsification surgery with IOL implantation. Direct microscopic examination showed that both formulations achieved the condition that particle size in ophthalmic suspension must be less than one micron.
References used
1. O’Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin 2005;21:1131-7.
2. Bilge AH, Aykan U, Akin T, Unsal U. Review of sterile, postoperative, anterior segment inflammation following cataract extraction and intraocular lens implantation. Eur J Ophthalmol. 2005;15:224-7.
3. Goguen ER, Roberts CW. Topical NSAIDs to control pain in clear corneal cataract exraction. Insight 2004;29:10-1.
4. Flach AJ, Dolan BJ, Donahue ME, et al. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Ophthal 1998;105:1775-9.
5. McColgin AZ, Heier JS. Control of intraocular inflammation associated with cataract surgery. Curr Opin Ophthal 2000;11:3-6.
6. McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf 2002; 25:33-55.
7. Holmberg BJ, Maggs DJ. The use of corticosteroids to treat ocular inflammation. Vet Clin North Am Small Anim Pract 2004;34:693-705.
8. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 2003;136:593-602.
9. Schalnus R. Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica 2003;217:89-98.
10. Gaynes BI, Fiscella R. Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review. Drug Saf 2002;25:233-50.
11. Hayasaka Y, Hayasaka S, Zhang XY, Nagaki Y. Effects of topical corticosteroids and nonsteroidal anti-inflammatory drugs on prostaglandin E2-induced aqueous flare elevation in pigmented rabbits. Ophthalmic Res 2003;35:341-4.
12. Nelson PL, Roberts C. Comparative analysis of prednisolone acetate suspensions. Invest Ophthalmol Vis Sci 2005;46(Suppl):1750.
13. Basic Clinical Science Course (BCSC) of the American Academy of Ophthalmology. Section 2, Fundamentals and Principles of Ophthalmology. 2014 – 2015.
14. Diestelhorst, M., Kwon, K.A., and Suverkrup, R. Dose uniformity of ophthalmic suspensions. J. Cataract Refract. Surg. 24:672–677, 1998.
15. Yasueda, S., Inada, K., Matsuhisa, K., et al. Evaluation of ophthalmic suspensions using surface tension. Eur. J. Pharm. Biopharm. 57:377–382, 2004.
16. en.wikipedia.org/wiki/ImageJ#Features (Last visited on 15 July 2017).
17. Schneider CA, Rasband WS, Eliceiri KW (2012). "NIH Image to ImageJ: 25 years of image analysis". Nat Methods. 9 (7): 671–675.
22. Gering E, Atkinson C (2004). "A rapid method for counting nucleated erythrocytes on stained blood smears by digital image analysis". J Parasitol. 90 (4): 879–81.
23. Burger W, Burge M (2007). Digital Image Processing: An Algorithmic Approach Using Java. Springer. ISBN 1-84628-379-5.
24. Dougherty, G (2009). Digital Image Processing for Medical Applications. Cambridge University Press. ISBN 978-0-521-86085-7.
25. Pred Forte [package insert]. Irvine, CA: Allergan, Inc., 2001.